Skip to main content

Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply.

Publication ,  Journal Article
Armstrong, AJ; Nordle, O; Morris, M
Published in: JAMA Oncol
February 1, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Oncol

DOI

EISSN

2374-2445

Publication Date

February 1, 2019

Volume

5

Issue

2

Start / End Page

270 / 271

Location

United States

Related Subject Headings

  • Prostatic Neoplasms, Castration-Resistant
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Neoplasms, Second Primary
  • Male
  • Humans
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Nordle, O., & Morris, M. (2019). Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply. JAMA Oncol, 5(2), 270–271. https://doi.org/10.1001/jamaoncol.2018.5874
Armstrong, Andrew J., Orjan Nordle, and Michael Morris. “Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply.JAMA Oncol 5, no. 2 (February 1, 2019): 270–71. https://doi.org/10.1001/jamaoncol.2018.5874.
Armstrong AJ, Nordle O, Morris M. Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply. JAMA Oncol. 2019 Feb 1;5(2):270–1.
Armstrong, Andrew J., et al. “Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply.JAMA Oncol, vol. 5, no. 2, Feb. 2019, pp. 270–71. Pubmed, doi:10.1001/jamaoncol.2018.5874.
Armstrong AJ, Nordle O, Morris M. Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply. JAMA Oncol. 2019 Feb 1;5(2):270–271.

Published In

JAMA Oncol

DOI

EISSN

2374-2445

Publication Date

February 1, 2019

Volume

5

Issue

2

Start / End Page

270 / 271

Location

United States

Related Subject Headings

  • Prostatic Neoplasms, Castration-Resistant
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Neoplasms, Second Primary
  • Male
  • Humans
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis